RSS - Posts
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine
|
|||||
      |
 One comment - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, Europe, genomics, grant, life sciences, nanotechnology, pharmaceuticals, physical sciences, university 
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies Comments are closed New products biomedical, biotechnology, cancer, chemistry, engineering, life sciences, manufacturing, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, engineering, genomics, life sciences, nanotechnology, pharmaceuticals, physical sciences 
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round. . . . → Read More: Cancer Detection Start-Up Gains $4M in Seed Funds Comments are closed Finance, New products biomedical, cancer, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, medical device, nanotechnology, physical sciences, university, venture capital 
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, entrepreneurs, genomics, life sciences, nanotechnology, NIH, pharmaceuticals, physical sciences, preclinical, U.K., university 
Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test One comment - (Comments are closed) New products biomedical, biotechnology, cancer, genomics, life sciences, nanotechnology, pharmaceuticals, preclinical 
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, heart disease, investment, life sciences, nanotechnology, pharmaceuticals, preclinical, university, venture capital 
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, Covid-19, Europe, genomics, grant, licensing, life sciences, nanotechnology, preclinical, university 
A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway One comment - (Comments are closed) Finance, New products biomedical, chemistry, computer science, engineering, entrepreneurs, equity, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, physics, preclinical, semiconductors, university, venture capital 
National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder. . . . → Read More: NIH Funding Nanoparticle Gene Therapy for Opioid Disorder Comments are closed Finance, Joint ventures/collaborations, New products biomedical, biotechnology, engineering, genomics, grant, life sciences, nanotechnology, NIH, pharmaceuticals, preclinical, university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||